For the first time we suggested that developed resistance to venetoclax could be due to the observed overexpression of BCLXL. Accordingly, it was recently demonstrated that venetoclax resistance was associated with increased BCLXL level in a CLL patient21. The gene discussed is BCL2L1; the disease is B-cell chronic lymphocytic leukemia.